Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
2,570 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00002487 | Methotrexate Plus Dipyridamole in Treating Patients With Advanced Ovarian Cancer | unknown | Phase 2 | — | Ottawa Regional Cancer CentreOTHER | 1 | Sep 17, 2013 | clinicaltrials |
| NCT00002488 | Combination Chemotherapy in Treating Patients With Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma Who Have Not Responded to Anthracycline-Containing Combination Chemotherapy | unknown | Phase 2 | — | Ottawa Regional Cancer CentreOTHER | 1 | Sep 17, 2013 |
| clinicaltrials |
| NCT00799136 | A Feasibility Study of Co-administering Combination Antiretroviral Therapy (cART) and R-EPOCH Chemotherapy for the Management of ARL(CATCH) | completed | Phase 2 | 6 | Ontario Clinical Oncology Group (OCOG)OTHER | 1 | Sep 12, 2013 | clinicaltrials |
| NCT00004203 | Oxaliplatin in Treating Patients With Metastatic Bladder Cancer | completed | Phase 2 | 20 | University of ChicagoOTHER | 2 | Sep 5, 2013 | clinicaltrials |
| NCT00004224 | Combination Chemotherapy Followed by Radiation Therapy in Treating Children With Localized Ependymoma | completed | Phase 2 | 65 | Societe Internationale d'Oncologie PediatriqueOTHER | 7 | Aug 26, 2013 | clinicaltrials |
| NCT00684918 | Study of Obatoclax in Previously Untreated Acute Myeloid Leukemia (AML) | completed | Phase 2 | 18 | Gemin XINDUSTRY | 2 | Aug 26, 2013 | clinicaltrials |
| NCT00003203 | Carboplatin and Vincristine Plus Radiation Therapy Followed By Adjuvant Chemotherapy in Treating Young Patients With Newly Diagnosed CNS Embryonal Tumors | completed | Phase 2 | 168 | Children's Oncology GroupNETWORK | 3 | Aug 23, 2013 | clinicaltrials |
| NCT00019422 | Lobradimil and Carboplatin in Treating Children With Brain Tumors | completed | Phase 2 | — | National Cancer Institute (NCI)NIH | 7 | Aug 16, 2013 | clinicaltrials |
| NCT00006470 | Vaccine Therapy Plus Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer That Has Been Completely Removed in Surgery | completed | Phase 2 | — | Radiation Therapy Oncology GroupNETWORK | 2 | Aug 13, 2013 | clinicaltrials |
| NCT00315757 | Study of Mapatumumab in Combination With Bortezomib (Velcade) and Bortezomib Alone in Subjects With Relapsed or Refractory Multiple Myeloma | completed | Phase 2 | 105 | Human Genome Sciences Inc.INDUSTRY | 4 | Aug 8, 2013 | clinicaltrials |
| NCT00006760 | Combination Chemotherapy in Treating Children With Refractory or Relapsed Hodgkin's Lymphoma | completed | Phase 2 | 66 | Children's Oncology GroupNETWORK | 3 | Jul 26, 2013 | clinicaltrials |
| NCT00070304 | Gemcitabine and Vinorelbine in Treating Young Patients With Recurrent or Refractory Hodgkin's Lymphoma | completed | Phase 2 | 33 | Children's Oncology GroupNETWORK | 5 | Jul 26, 2013 | clinicaltrials |
| NCT00002873 | Radiation Therapy in Treating Women With Stage I or Stage II Breast Cancer | completed | Phase 1 / Phase 2 | — | Radiation Therapy Oncology GroupNETWORK | 2 | Jul 19, 2013 | clinicaltrials |
| NCT00006258 | Combination Chemotherapy Followed by Radiation Therapy in Treating Patients With Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Ependymoma | completed | Phase 2 | — | Children's Hospital Los AngelesOTHER | 2 | Jul 18, 2013 | clinicaltrials |
| NCT00678119 | Study Testing the Biologic Activity and Safety of a Immunotherapeutic in Patients With Newly Diagnosed Advanced Stage Kidney Cancer in Combination With a Marketed Renal Cell Carcinoma Treatment | completed | Phase 2 | 25 | Argos TherapeuticsINDUSTRY | 2 | Jul 15, 2013 | clinicaltrials |
| NCT00002608 | Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors | completed | Phase 2 | 30 | Ottawa Regional Cancer CentreOTHER | 1 | Jul 10, 2013 | clinicaltrials |
| NCT00529100 | Concurrent Pemetrexed, Cisplatin and Radiation Therapy in Patients With Stage IIIA/B Non Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 49 | Eli Lilly and CompanyINDUSTRY | 1 | Jul 9, 2013 | clinicaltrials |
| NCT00003811 | Combination Chemotherapy Plus Amifostine in Treating Children With Malignant Germ Cell Tumors | completed | Phase 2 | 27 | Children's Oncology GroupNETWORK | 6 | Jul 4, 2013 | clinicaltrials |
| NCT00017160 | Combination Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Primary or Recurrent Sarcoma | withdrawn | Phase 2 | 0 | Radiation Therapy Oncology GroupNETWORK | 2 | Jun 27, 2013 | clinicaltrials |
| NCT00003101 | Combination Chemotherapy and Bone Marrow Transplantation or Peripheral Stem Cell Transplantation in Treating Patients With Oligodendroglioma | completed | Phase 2 | 60 | Memorial Sloan Kettering Cancer CenterOTHER | 2 | Jun 25, 2013 | clinicaltrials |
| NCT00023699 | Gefitinib in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer or Primary Peritoneal Cancer | completed | Phase 2 | — | Gynecologic Oncology GroupNETWORK | 4 | Jun 24, 2013 | clinicaltrials |
| NCT00023725 | Radiation Therapy With or Without SU5416 in Treating Patients With Soft Tissue Sarcoma | completed | Phase 1 / Phase 2 | — | Radiation Therapy Oncology GroupNETWORK | 2 | Jun 24, 2013 | clinicaltrials |
| NCT00023738 | Chemotherapy, SU5416, Radiation Therapy, and Surgery in Treating Patients With Soft Tissue Sarcoma | completed | Phase 1 / Phase 2 | — | Radiation Therapy Oncology GroupNETWORK | 2 | Jun 24, 2013 | clinicaltrials |
| NCT00023894 | Flavopiridol in Treating Patients With Recurrent or Persistent Endometrial Cancer | completed | Phase 2 | — | Gynecologic Oncology GroupNETWORK | 5 | Jun 24, 2013 | clinicaltrials |
| NCT00032123 | Erlotinib in Treating Patients With Locally Advanced or Metastatic Stomach Cancer or Gastroesophageal Junction Cancer | completed | Phase 2 | — | SWOG Cancer Research NetworkNETWORK | 2 | Jun 24, 2013 | clinicaltrials |
| NCT00068289 | Bortezomib in Treating Patients With Recurrent or Refractory Extensive-Stage Small Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy | completed | Phase 2 | — | SWOG Cancer Research NetworkNETWORK | 2 | Jun 24, 2013 | clinicaltrials |
| NCT00328770 | De Novo Sirolimus-based Immunosuppression After Liver Transplantation for Hepatocellular Carcinoma | completed | Phase 2 / Phase 3 | 70 | University of AlbertaOTHER | 1 | Jun 24, 2013 | clinicaltrials |
| NCT00773383 | A Study of the Effect of R1507 in Combination With Tarceva (Erlotinib) on Progression-Free Survival in Patients With Stage IIIb/IV Non-Small Cell Lung Cancer (NSCLC) Having Received Tarceva Monotherapy. | terminated | Phase 2 | 35 | Hoffmann-La RocheINDUSTRY | 4 | Jun 24, 2013 | clinicaltrials |
| NCT00003523 | Aminocamptothecin in Treating Patients With Recurrent or Refractory Ovarian Epithelial Cancer or Primary Cancer of the Peritoneum | completed | Phase 2 | — | Gynecologic Oncology GroupNETWORK | 2 | Jun 21, 2013 | clinicaltrials |
| NCT00005836 | Oxaliplatin in Treating Patients With Recurrent or Refractory Ovarian Epithelial Cancer or Primary Peritoneal Cancer That Has Not Responded to Platinum- Based Chemotherapy | completed | Phase 2 | — | Gynecologic Oncology GroupNETWORK | 2 | Jun 21, 2013 | clinicaltrials |
| NCT00005837 | Oxaliplatin in Treating Patients With Recurrent or Refractory Cervical Cancer | completed | Phase 2 | — | Gynecologic Oncology GroupNETWORK | 2 | Jun 21, 2013 | clinicaltrials |
| NCT01050621 | Trial of Chemotherapy Plus Intravenous Vitamin C in Patients With Advanced Cancer for Whom Chemotherapy Alone is Only Marginally Effective | completed | Phase 1 / Phase 2 | 14 | Jewish General HospitalOTHER | 1 | Jun 21, 2013 | clinicaltrials |
| NCT00530764 | A Study of Sativex® for Pain Relief in Patients With Advanced Malignancy.(SPRAY) | completed | Phase 2 | 360 | GW Pharmaceuticals LtdINDUSTRY | 16 | Jun 20, 2013 | clinicaltrials |
| NCT00993486 | Dose-ranging Study of a Single Administration of T-cell Add-back Depleted of Host Alloreactive Cells in Patients Undergoing a Peripheral Blood Stem Cell Transplant From a Related, Haploidentical Donor | completed | Phase 1 / Phase 2 | 19 | Kiadis PharmaINDUSTRY | 1 | Jun 20, 2013 | clinicaltrials |
| NCT01571401 | Trying Activity in Kidney Cancer Survivors (TRACKS) Trial(TRACKS) | completed | Phase 2 | 32 | University of AlbertaOTHER | 1 | Jun 19, 2013 | clinicaltrials |
| NCT00908024 | Combination Study of BMS-754807 and Erbitux® in Subjects With Advanced or Metastatic Solid Tumors | terminated | Phase 1 / Phase 2 | 54 | Bristol-Myers SquibbINDUSTRY | 2 | Jun 18, 2013 | clinicaltrials |
| NCT00096395 | Sorafenib Tosylate and Gemcitabine Hydrochloride in Treating Patients With Recurrent Epithelial Ovarian Cancer | completed | Phase 2 | 33 | National Cancer Institute (NCI)NIH | 1 | Jun 13, 2013 | clinicaltrials |
| NCT00003946 | Danazol in Treating Patients With Advanced or Recurrent Endometrial Cancer | completed | Phase 2 | — | Gynecologic Oncology GroupNETWORK | 2 | Jun 10, 2013 | clinicaltrials |
| NCT00005643 | Chemotherapy in Treating Patients With Sarcoma of the Uterus | completed | Phase 2 | — | Gynecologic Oncology GroupNETWORK | 2 | Jun 10, 2013 | clinicaltrials |
| NCT01293942 | IXO+A in mCRC With Liver-only Metastases | withdrawn | Phase 2 | 0 | Ottawa Hospital Research InstituteOTHER | 1 | Jun 5, 2013 | clinicaltrials |
| NCT00005976 | Pyrazoloacridine Plus Carboplatin in Treating Patients With Recurrent Glioma | completed | Phase 2 | 60 | National Cancer Institute (NCI)NIH | 2 | Jun 3, 2013 | clinicaltrials |
| NCT00005031 | Irofulven in Treating Patients With Persistent or Recurrent, Refractory Endometrial Cancer | completed | Phase 2 | — | Gynecologic Oncology GroupNETWORK | 2 | May 27, 2013 | clinicaltrials |
| NCT00558272 | Study to Evaluate the Safety and Effects AZD0530 on Prostate and Breast Cancer Subjects With Metastatic Bone Disease | completed | Phase 2 | 139 | AstraZenecaINDUSTRY | 8 | May 27, 2013 | clinicaltrials |
| NCT01733836 | Prostate Cancer Active Surveillance Metformin Trial | withdrawn | Phase 2 | 0 | University Health Network, TorontoOTHER | 1 | May 24, 2013 | clinicaltrials |
| NCT00045695 | Bortezomib in Treating Patients With Waldenstrom's Macroglobulinemia | completed | Phase 2 | 27 | NCIC Clinical Trials GroupNETWORK | 2 | May 17, 2013 | clinicaltrials |
| NCT00095953 | SB-715992 in Treating Patients With Metastatic or Recurrent Malignant Melanoma | completed | Phase 2 | 17 | NCIC Clinical Trials GroupNETWORK | 1 | May 17, 2013 | clinicaltrials |
| NCT00707889 | Phase 2 Study of ABT-869 in Combination With mFOLFOX6 Versus Bevacizumab in Combination With mFOLFOX6 to Treat Advanced Colorectal Cancer | completed | Phase 2 | 159 | AbbVie (prior sponsor, Abbott)INDUSTRY | 14 | May 15, 2013 | clinicaltrials |
| NCT00363051 | Safety/Efficacy of Everolimus in Adults With Advanced Pancreatic Neuroendocrine Cancer Not Responsive to Chemotherapy | completed | Phase 2 | 160 | Novartis PharmaceuticalsINDUSTRY | 11 | May 10, 2013 | clinicaltrials |
| NCT00095667 | Lapatinib in Treating Patients With Recurrent or Metastatic Prostate Cancer | completed | Phase 2 | 41 | National Cancer Institute (NCI)NIH | 1 | May 8, 2013 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials